Eric N. Shiozaki
Direktor/Vorstandsmitglied bei Unlearn.AI, Inc.
Profil
Eric N.
Shiozaki is currently a Director at Unlearn.
AI, Inc. and a Partner at DCVC Management Co. LLC.
Previously, he was a Director at PROCEPT BioRobotics Corp., an Associate at Burrill LLC, a Director of Corporate Development & Strategy at VitaPath Genetics, Inc., and a Director at Apposite Capital LLP.
From 2014 to 2021, he was a Partner at Novo Ventures (US), Inc. Shiozaki received his undergraduate degree from The Johns Hopkins University in 1999 and his doctorate from Princeton University in 2003.
Aktive Positionen von Eric N. Shiozaki
Unternehmen | Position | Beginn |
---|---|---|
DCVC Management Co. LLC
DCVC Management Co. LLC Investment ManagersFinance DCVC Management Co LLC (DCVC) is a venture capital firm founded in 2011 by Zachary Bogue and Matthew Ocko. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01.06.2021 |
Unlearn.AI, Inc.
Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Eric N. Shiozaki
Unternehmen | Position | Ende |
---|---|---|
Novo Ventures (US), Inc.
Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden. | Private Equity Investor | 01.06.2021 |
Apposite Capital LLP
Apposite Capital LLP Investment ManagersFinance Apposite Capital LLP (Apposite Capital) is a private equity arm of Mizuho Financial Group, Inc. founded in 2016 by David Porter. The firm is headquartered in London, United Kingdom. | Private-Equity-Analyst | 31.05.2014 |
Burrill LLC
Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Private-Equity-Analyst | 31.12.2009 |
VitaPath Genetics, Inc.
VitaPath Genetics, Inc. Medical/Nursing ServicesHealth Services VitaPath Genetics is developing a family of DNA tests to help individuals reduce the risk of serious and life-threatening disease. The company's first product is a genetic test to identify risk factors that are associated with a common birth defect called Spina Bifida and which can be safely corrected with low-risk vitamin supplementation under the care of a physician. At VitaPath, it mission is to focus only on genetic mutations that are shown to be biologically functional and that can be remediated with minimal risk. In doing so, it can improve the quality of life for customers and reduce the overall cost of healthcare. | Direktor/Vorstandsmitglied | 31.07.2009 |
PROCEPT BIOROBOTICS CORPORATION | Direktor/Vorstandsmitglied | - |
Ausbildung von Eric N. Shiozaki
The Johns Hopkins University | Undergraduate Degree |
Princeton University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PROCEPT BIOROBOTICS CORPORATION | Health Technology |
Private Unternehmen | 6 |
---|---|
Burrill LLC
Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Finance |
Apposite Capital LLP
Apposite Capital LLP Investment ManagersFinance Apposite Capital LLP (Apposite Capital) is a private equity arm of Mizuho Financial Group, Inc. founded in 2016 by David Porter. The firm is headquartered in London, United Kingdom. | Finance |
VitaPath Genetics, Inc.
VitaPath Genetics, Inc. Medical/Nursing ServicesHealth Services VitaPath Genetics is developing a family of DNA tests to help individuals reduce the risk of serious and life-threatening disease. The company's first product is a genetic test to identify risk factors that are associated with a common birth defect called Spina Bifida and which can be safely corrected with low-risk vitamin supplementation under the care of a physician. At VitaPath, it mission is to focus only on genetic mutations that are shown to be biologically functional and that can be remediated with minimal risk. In doing so, it can improve the quality of life for customers and reduce the overall cost of healthcare. | Health Services |
DCVC Management Co. LLC
DCVC Management Co. LLC Investment ManagersFinance DCVC Management Co LLC (DCVC) is a venture capital firm founded in 2011 by Zachary Bogue and Matthew Ocko. The firm is headquartered in San Francisco, California. | Finance |
Novo Ventures (US), Inc.
Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden. | Finance |
Unlearn.AI, Inc.
Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | Technology Services |